Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong
About this trial
Since much is unknown about factors that lead to progression of the pre-neoplastic lesions and cancer. In addition, there is ongoing debate on the optimal surveillance intervals and techniques. To solve these important clinical questions, the establishment of a registry for a longitudinal study is planned.
Eligibility criteria
Qualifiers
Adults >= 18 years of age
Written informed consent obtained
Diagnosed with current or past H. pylori infection,
Histologically proven atrophic gastritis (body and/or antrum of stomach), intestinal metaplasia (complete and incomplete), dysplasia (any grade) and/or gastric cancer (post- treatment)
Disqualifiers
Co-morbid illness that prohibit endoscopic surveillance
Declines for study questionnaire, biobanking of specimens and/or regular review per study protocol
Trial design
Treatments tested in this trial
- Esophagogastroduodenoscopy
Treatment groups
No treatment groups listed
Locations
2Prince of Wales Hospital Hong Kong Hong Kong
S.H. Ho Centre for Digestive Health, Prince of Wales Hospital Hong Kong Hong Kong
Sponsors and collaborators
Chinese University of Hong Kong
Lead sponsor
Source ClinicalTrials.gov